Managing cardiovascular risk in overweight children and adolescents

Sarita Dhuper1, Sujatha Buddhe, Sunil Patel

  • 1Department of Pediatric Cardiology, Brookdale University Hospital and Medical Center, 1 Brookdale Plaza, Room 300CHC, Brooklyn, NY 11212, USA. sdhuper@brookdale.edu

Paediatric Drugs
|April 13, 2013
PubMed

Insights

Obesity is a global health crisis, leading to serious co-morbidities like hypertension and type 2 diabetes in children. Early detection and treatment strategies are crucial for managing these conditions and preventing premature death.

Area of Science:

  • Public Health
  • Cardiology
  • Pediatrics

Background:

  • The global epidemic of obesity presents a significant medical and public health challenge.
  • Obesity is increasingly associated with severe co-morbidities, becoming a leading cause of premature death.
  • Pediatric and adult cardiologists observe a rise in young patients with obesity-related diseases like hypertension, dyslipidemia, metabolic syndrome, and type 2 diabetes.

Purpose of the Study:

  • To review current literature and recommendations from the American Heart Association (AHA) and American Academy of Pediatrics (AAP).
  • To discuss metabolic abnormalities associated with obesity in children and adolescents.
  • To highlight newer strategies for identifying and treating obesity, dyslipidemia, and early subclinical coronary artery disease in high-risk youth.

Main Methods:

  • Literature review.
  • Analysis of scientific statements and recommendations from leading medical organizations (AHA, AAP).

Main Results:

  • Obesity in children and adolescents is linked to early onset of serious conditions like hypertension, dyslipidemia, metabolic syndrome, type 2 diabetes, and preclinical atherosclerotic cardiovascular disease.
  • There is a growing need for updated identification and treatment strategies for these conditions in pediatric populations.

Conclusions:

  • The rising prevalence of childhood obesity necessitates urgent attention and updated management approaches.
  • Early identification and intervention for obesity-related metabolic and cardiovascular issues in children and adolescents are critical for long-term health outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.